Remepy

USANYCBiotech & PharmaSeries A

Overview

Where Remepy is now

Remepy announced a Series A round of $36M on 12 August 2026, led by O.G.

Observed Described in the funding announcement as "provider of a platform for hybrid drugs that combine prescription medicines with personalized, AI-driven therapeutic apps". Source

Latest round
Series A
Amount
$36M
Announced
12 August 2026
Headquarters
NYC, USA
Sector
Biotech & Pharma
Investors
O.G
Also participating
existing and new investors including NFX, Vine Ventures, Qumra Capital, TechAviv, 97212 Ventures, Fresh Fund, PsyMed Ventures, Tadmor Group, Key1 Capital, and IT-Farm Corp
Relevant leadership
Co-CEOs Michal Tsur and Or Shoval

Current direction Inferred

What this company is working on

Market expansionProductResearch and developmentPartnerships

Read from the company's own description of what the funding supports.

Momentum Inferred

AfterRaise Score

71
Building momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
16/25
round size relative to the market
Funding stage
15/20
Series A
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 12 August 2026
    $36M Series A
    Led by O.G.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for Remepy from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach Remepy

Not yet specified

Remepy has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Remepy.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Biotech & Pharma companies

See the sector